Recombinant Mouse CYP2F2 Protein，His

CYP2F2 is a member of the cytochrome P450 enzyme family, which plays a crucial role in the metabolism of various endogenous and exogenous compounds, including drugs, steroids, and environmental toxins. It is primarily expressed in the lungs and is implicated in the biotransformation of nicotine and other xenobiotics. Research into CYP2F2 is vital due to its potential impact on drug metabolism and toxicology, particularly in understanding individual responses to medications and the risks associated with exposure to airborne pollutants. The study of CYP2F2 recombinant proteins allows scientists to investigate its functional properties, substrate specificity, and interactions with various inhibitors or inducers. This understanding can lead to advancements in personalized medicine, where genetic variations in CYP2F2 may influence therapeutic outcomes. Furthermore, elucidating the biochemical pathways involving CYP2F2 can provide insights into the pharmacokinetics of substances that undergo metabolism by this enzyme, thereby enhancing drug safety and efficacy. The recombinant expression of CYP2F2 also paves the way for the development of novel therapeutic agents and can aid in the design of more effective drug formulations by predicting metabolic pathways and interactions. Overall, the research on CYP2F2 recombinant proteins holds significant promise for improving health outcomes and understanding metabolic processes in human physiology.